Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2026-05-28 16:11:20 ET · period of report 2026-05-26 · accession 0001193125-26-245237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-28 16:11 | 2026-05-26 | DYN | Posner Brian S | Dir | P - Purchase | $18.21 | +2,000 | 20.0K | +11% | +$36.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-26 | P | A | 2,000 | $18.21 | 20,000 | D | — | — |